Great. Thanks, Shai. I'll review highlights of our Q1 results and provide our expectations for Q2 and the full year, and then we'll take some questions. As Daniel and Shai noted, it was a great quarter with good progress on all of our key metrics, including growth, gross loss ratio, and our cash outlook. Premium per customer increased 8% versus the prior year to $379, driven primarily by rate increases. Annual dollar retention or ADR was 88%, up 1 percentage point since this time last year. We measure ADR on an annual cohort basis and include the impact of changes in policy value, additional policy purchases, and churn. Gross earned premium in Q1 increased 22% as compared to the prior year to $188 million, in line with our IFP growth. And revenue in Q1 increased 25% from the prior year to $119 million. The growth in revenue was driven by the increase in gross earned premium, a slightly higher effective ceding commission rate under our quota share reinsurance, primarily related to reserve adjustments and a near doubling of investment income. Our gross loss ratio was 79% for Q1 as compared to 87% in Q1 2023 and 77% in Q4 2023. The impact of catastrophes or CATs in Q1 was roughly 16 percentage points within the gross loss ratio and nearly all driven by convective storm and winter storm activity. Absent this total CAT impact, the underlying gross loss ratio was 63% and 9 points better than the prior quarter and nearly 10 percentage points better than the prior year. Our prior period development was a roughly 6% favorable impact in the quarter. And worth noting that the CAT or catastrophe prior period development impact was about 2% unfavorable, while non-CAT was about 8% favorable. Given the notable ups and downs of the quarterly gross loss ratio, it's all the more useful to continue to consider our rolling 4-quarter view of loss ratio, which we include again in our shareholder letter to get a feel for the longer-term trends for loss ratio. Our trailing 12 months or TTM loss ratio was about 83%, and this is 6 points better year-on-year. From a product perspective, loss ratios improved across the business as compared to the prior year with the exception of home, which did not. Gross profit and adjusted gross profit has shown notable improvement over time, driven by continued premium growth coupled with loss ratio and investment income improvements. Q1 gross profit increased by 110% to $35 million versus the prior year, while adjusted gross profit increased by 78% over the same period. Gross profit has grown significantly more than tripling in 2 years, while quarterly adjusted gross profit has more than doubled over that same period. Operating expenses excluding loss and loss adjustment expense increased just 2% to $98 million in Q1 as compared to the prior year. Other insurance expense grew 27% in Q1 versus the prior year, a bit more than the growth of earned premium, primarily in support of our increased investment in rate filing capacity. Total sales and marketing expense increased by $2 million or 8%, primarily due to our increased growth spend, which was partially offset by lower personnel-related costs driven by efficiency gains. Total growth spend in the quarter was $19.8 million, up about 14% as compared to the prior year. We continue to utilize our Synthetic Agents growth funding program and have financed 80% of our growth spend since the start of the year. As a reminder, you will see 100% of our growth spend flow through the P&L as always, while the impact of the new growth mechanism is visible on the cash flow statement in the balance sheet and the net financing to date through our Synthetic Agents program is about $28 million as of the end of Q1. Our technology development expense declined 4% to $21 million due primarily to personnel cost efficiencies. And our G&A expense declined 9% as compared to the prior year to $30 million, primarily due to lower professional service fees and lower insurance costs. Personnel expense and headcount control continue to be a high priority. Total headcount is down about 11% as compared to the prior year at 1,236, while, again, our top line IFP grew about 22% same period. Our net loss was a loss of $47 million in Q1 or a loss of $0.67 per share. This was about 28% better as compared to the $66 million loss, or $0.95 per share loss we reported in the first quarter of 2023. Our adjusted EBITDA loss was a loss of $34 million in Q1 as compared to the $51 million adjusted EBITDA loss in the first quarter of 2023, or about 33% better. Our total cash, cash equivalents, and investments ended the quarter at approximately $927 million, down just 2% since year-end 2023. And with these metrics in mind, I'll outline our specific financial expectations for the second quarter and for the full year '24. For the second quarter, we expect in-force premium at June 30 between $839 million and $841 million, gross earned premium between $197 million and $199 million, revenue of between $118 million and $120 million, and an adjusted EBITDA loss of between $49 million and $47 million. We expect stock-based compensation expense of approximately $15 million in the quarter, capital expenditures of approximately $3 million, and a weighted average share count of approximately 70 million shares. And for the full year of 2024, we expect in-force premium at December 31 of between $940 million and $944 million, gross earned premium between $818 million and $822 million, revenue of between $511 million and $515 million, and an adjusted EBITDA loss of between $155 million and $151 million. For the full year, we expect stock-based compensation expense of approximately $62 million, capital expenditures approximately $10 million, and a weighted average share count of approximately 71 million shares. And with that, I'd like to hand things back over to Shai to answer a few questions from our retail investors.